• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

    1.360 +0.110 (+8.80%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,661,028
    Open 1.250
    Bid (Size) 1.240 (3,000)
    Ask (Size) 1.400 (200)
    Prev. Close 1.250
    Today's Range 1.225 - 1.400
    52wk Range 1.140 - 9.500
    Shares Outstanding 89,348,107
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Did You Lose Money Investing in Anavex Life Sciences Corp.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against AVXL
    San Diego, California--(Newsfile Corp. - October 16, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class... 
    Via Newsfile
    Topics Lawsuit Regulatory Compliance

    Performance

    52-Week Range 85.7% below 52-week high
    1.360
    1.1452W Low 9.5052W High
    1 Week 12.3% below 1-week high
    1.141W Low 1.551W High

    Anavex Life Sciences Corp. - Common Stock (AVXL) traded between $1.14 and $9.50 over the past 52 weeks and last traded at $1.36, 85.7% below its 52-week high. Over the past week it ranged between $1.14 and $1.55.

    Past 12 Months
    -8.1%
    -43.3%
    -43.8%
    -62.7%
    -63.0%
    -85.5%
    1W -$0.12
    1M -$1.04
    3M -$1.06
    6M -$2.29
    YTD -$2.32
    1Y -$8.00

    AVXL was -85.5% over the past year, -62.7% over six months, -63.0% year to date, -8.1% in the last week.

    12 Months vs Market
    AVXL
    -85.5%
    DIA
    +12.3%
    SPY
    +14.6%
    QQQ
    +17.3%
    IWM
    +11.1%

    Over the past 12 months AVXL returned -85.5% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

    Volume & Liquidity 1.63× 3-mo avg
    Today 1,661,028 3-mo avg 1.0M
    1W
    1.5M
    1M
    1.4M
    3M
    1.0M
    6M
    1.1M
    YTD
    1.3M
    1Y
    1.6M

    AVXL most recently traded 1,661,028 shares against a 3-month average daily volume of 1.0M.

    More News

    Read More
    News headline image
    AVXL Investors: Anavex Life Sciences Corp. Shares Declined By $0.19 On August 31, 2026 – Contact Kirby McInerney LLP to Discuss Your Rights
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    AVXL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Deadline Approaching: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) to Contact the Firm to Learn About Their Legal Rights
    Via NewMediaWire
    Topics Lawsuit Regulatory Compliance
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Deadline Soon: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Law Offices of Howard G. Smith Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    AVXL Shareholder Alert: November 30, 2026 Lead Plaintiff Deadline in Anavex Life Sciences Corp. Securities Class Action - Contact Levi & Korsinsky
    From Levi & Korsinsky, LLP
    Via ACCESS Newswire
    News headline image
    AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Law Offices of Frank R. Cruz Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Class Action Filed Against Anavex Life Sciences Corp. – AVXL Investors Encouraged to Contact Kirby McInerney LLP
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire

    Frequently Asked Questions

    Is Anavex Life Sciences Corp. - Common Stock publicly traded?
    Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.
    What exchange does Anavex Life Sciences Corp. - Common Stock trade on?
    Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?
    The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market
    What is the current price of Anavex Life Sciences Corp. - Common Stock?
    The current price of Anavex Life Sciences Corp. - Common Stock is 1.360
    When was Anavex Life Sciences Corp. - Common Stock last traded?
    The last trade of Anavex Life Sciences Corp. - Common Stock was at 10/20/26 04:00 PM ET
    What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?
    The market capitalization of Anavex Life Sciences Corp. - Common Stock is 121.51M
    How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?
    Anavex Life Sciences Corp. - Common Stock has 122M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.